(Total Views: 113)
Posted On: 01/19/2022 8:41:17 AM
Post# of 38278
$QNTA News January 19, 2022
Medolife Rx, Inc. ("Medolife"
(OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-su...00052.html
Medolife Rx, Inc. ("Medolife"
(OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-su...00052.html
(0)
(0)
